Please Wait.....
Report
Regenerative Medicines: Bone and Joint Applications
Market Research Report I 2022-06-10 I 105 Pages I BCC Research
Description
Report Scope:
The report explains critical trends in the regenerative medicine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.
This study looks at most of the systems affected by factors such as R&D spending and increasing competition and new technologies.
This report also covers merger and acquisition strategies and collaborations, as well as the strengths and weaknesses of each strategy type.
The market has also been analyzed based on regenerative medicine for bone and joint applications. Categories considered in this report include allogeneic bones, autogenic bones, bone graft substitutes, osteoarticular diseases and others.
The report provides information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.
Report Includes:
- 51 tables
- An overview of the global market for regenerative medicines for bone and joint applications
- Estimation of the market size and analyses of global market trends, with data from 2020 to 2021, estimates for 2022, with projections of compound annual growth rates (CAGRs) through 2027
- Characterization and quantification of market potential for regenerative medicines by technology, application, and region
- Coverage and discussion on regulatory delays due to COVID-19, clinical trials and product launches of the industry
- Description of principle approaches to regenerative medicine and discussion on importance of scaffolding in tissue engineering
- Information on major drivers and regional dynamics of the market and current trends within the industry
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships and other key market strategies
- Company profiles of major players, including Anika Therapeutics, Conmed Corp., Johnson & Johnson and Stryker Corp.
Executive Summary
Summary:
The global market for regenerative medicine for bone and joint applications was valued at REDACTED in 2021. By technology, this market is segmented into biomaterials, stem cell therapy and tissue engineering. The tissue engineering segment recorded REDACTED revenue in 2021 and is expected to grow at a compound annual growth rate (CAGR) of REDACTED during the forecast period. The rapid growth rate of the tissue engineering segment is attributed to rising adoption of products that are designed and developed for the treatment of tissues such as bone, skeletal muscle, cartilage, blood vessel, nervetissue, skin and for complete organs.
Reasons for Doing This Study:
The purpose of this report is to provide a summary of regenerative medicine products for the treatment of diseases and disorders of the bones and joints. Regenerative therapies have the potential to progress medical outcomes, improve quality of life and decrease overall healthcare costs. A major objective is the utilization of living cells to repair or replace body tissue damaged by injury, disorder or the aging process. The most successful products draw upon multidisciplinary fields such as biology, medicine, engineering and, particularly, biomedical engineering. This report is designed to be a critical decisionmaking tool for the intended audience, which includes biopharmaceutical market players, potential market entrants and other professionals involved with or interested in cell and gene therapy and regenerative therapy in orthopedic sector.
Table of Contents
Chapter 1 Introduction
Background
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update?
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Overview of Regenerative Medicine
How Regenerative Medicine Works
Principal Approaches to Regenerative Medicine
Cells and Tissues
Tissue Engineering
Importance of Scaffolding in Tissue Engineering
Plastic Scaffolding
Blood Vessel Scaffolding
Center for Integration of Medicine and Innovative Technology (CIMIT)
Embryonic Stem Cells
Chapter 4 Impact of COVID-19
Overview
Impact of COVID-19 on Cell and Gene Therapies, and Regenerative Medicine for Bone and Joint Applications
Direct Impact on Clinical Trials in Cell and Gene Therapy
Chapter 5 Market Dynamics
Market Drivers
Rising Number of Bone and Joint Disorders and Orthopedic Surgeries
Increasing Product Approvals and Launches
R&D for Stem and Gene Therapies
Market Restraints
Stringent Government Regulatory Settings in R&D
Market Opportunities
Growing Pipeline for Regenerative Medicines
Competitive Landscape
Chapter 6 Market Breakdown by Technology
Global Market by Technology
Biomaterials
Biomaterials for Regeneration
Market Size and Forecast
Stem Cell Therapy
Market Size and Forecast
Tissue Engineering
Market Size and Forecast
Chapter 7 Market Breakdown by Application
Global Market by Application
Allogeneic Bones
Market Size and Forecast
Autogenic Bones
Market Size and Forecast
Bone Graft Substitutes
Market Size and Forecast
Osteoarticular Diseases
Market Size and Forecast
Other Diseases
Market Size and Forecast
Chapter 8 Market Breakdown by Region
Global Market by Region
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
Australia
India
Rest of Asia-Pacific
Rest of the World
Chapter 9 Company Profiles
ANIKA THERAPEUTICS INC.
ARTHREX INC.
BAXTER INTERNATIONAL INC.
BIOVENTUS
CONMED CORP.
DEPUY SYNTHES PRODUCTS INC. (PART OF JOHNSON & JOHNSON)
MEDTRONIC PLC
SEIKAGAKU CORP.
SMITH & NEPHEW PLC
STRYKER CORP.
ZIMMER BIOMET HOLDINGS INC.
Chapter 10 Appendix: List of Acronyms
List of Tables
Summary Table : Global Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table A : Comparison of Changes in the Segmentation of Previous and Current Version of Report
Table 1 : Top Three Companies in the Global Market for Regenerative Medicine for Bone and Joint Applications, 2021
Table 2 : Global Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 3 : Biomaterial-Assisted Gene Therapy in Musculoskeletal Research
Table 4 : Global Market for Biomaterials in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 5 : Global Market for Stem Cell Therapy in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 6 : Biomaterials Utilized for Specific Target Tissues and Cell Types
Table 7 : Global Market for Tissue Engineering in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 8 : Global Market for Regenerative Medicine for Bone and Joint Applications, by Application, Through 2027
Table 9 : Global Market for Allogeneic Bones in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 10 : Global Market for Autogenic Bones in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 11 : Global Market for Bone Graft Substitutes in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 12 : Global Market for Osteoarticular Diseases in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 13 : Global Market for Other Disease Applications in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 14 : Global Regenerative Medicine Market for Bone and Joint Applications, by Region, Through 2027
Table 15 : North American Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 16 : North American Market for Regenerative Medicine for Bone and Joint Applications, by Country, Through 2027
Table 17 : European Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 18 : European Market for Regenerative Medicine for Bone and Joint Applications, by Country, Through 2027
Table 19 : Asia-Pacific Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 20 : Asia-Pacific Market for Regenerative Medicine for Bone and Joint Applications, by Country, Through 2027
Table 21 : Rest of the World Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 22 : Anika Therapeutics: R&D Expenditures, 2019-2021
Table 23 : Anika Therapeutics: Products Offered
Table 24 : Anika Therapeutics: Recent Developments
Table 25 : Arthrex Inc.: Products Offered
Table 26 : Arthrex Inc.: Recent Developments
Table 27 : Baxter International: Products Offered
Table 28 : Bioventus: Products Offered
Table 29 : Bioventus: Recent Developments
Table 30 : Conmed Corp.: R&D Expenditures, 2019-2021
Table 31 : Conmed Corp.: Products Offered
Table 32 : Conmed Corp.: Recent Developments
Table 33 : Johnson & Johnson (DePuy Synthes Companies): R&D Expenditures, 2019-2021
Table 34 : Johnson & Johnson (DePuy Synthes Companies): Products Offered
Table 35 : Johnson & Johnson (DePuy Synthes Companies): Recent Developments
Table 36 : Medtronic PLC: R&D Expenditures, 2019-2021
Table 37 : Medtronic PLC: Products Offered
Table 38 : Medtronic PLC: Recent Developments
Table 39 : Seikagaku Corp.: Products Offered
Table 40 : Seikagaku Corp.: Recent Developments
Table 41 : Smith & Nephew: R&D Expenditures, 2019-2021
Table 42 : Smith & Nephew: Products Offered
Table 43 : Smith & Nephew: Recent Developments
Table 44 : Stryker Corp.: R&D Expenditures, 2019-2021
Table 45 : Stryker Corp.: Products Offered
Table 46 : Stryker Corp.: Recent Developments
Table 47 : Zimmer Biomet Holdings: R&D Expenditures, 2018-2020
Table 48 : Zimmer Biomet Holdings: Products Offered
Table 49 : Zimmer Biomet Holdings: Recent Developments
Table 50 : Acronyms Used in This Report
List of Figures
Summary Figure : Global Market Shares of Regenerative Medicine for Bone and Joint Applications, by Technology, 2021
Figure 1 : Global Market Shares of Regenerative Medicine for Bone and Joint Applications, by Technology, 2021
Figure 2 : Global Market for Regenerative Medicine for Biomaterials in the Bone and Joint Applications, 2020-2027
Figure 3 : Global Market for Biomaterials in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 4 : Global Market for Stem Cell Therapy in Bone and Joint Applications, 2020-2027
Figure 5 : Global Market for Stem Cell Therapy in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 6 : Global Market for for Tissue Engineering in Bone and Joint Applications, 2020-2027
Figure 7 : Global Market for Tissue Engineering in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 8 : Global Market Shares of Regenerative Medicine in Bone and Joint Applications, by Application, 2021
Figure 9 : Global Market for Allogeneic Bones in Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 10 : Global Market for Allogeneic Bones in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 11 : Global Market for Autogenic Bones in Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 12 : Global Market for Autogenic Bones in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 13 : Global Market for Bone Graft Substitutes in Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 14 : Global Market for Bone Graft Substitutes in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 15 : Global Market for Osteoarticular Diseases in Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 16 : Global Market for Osteoarticular Diseases in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 17 : Global Market for Other Applications in Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 18 : Global Market for Other Disease Applications in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 19 : Global Regenerative Medicine Market for Bone and Joint Applications, by Region, 2020-2027
Figure 20 : Global Market Shares of Regenerative Medicine for Bone and Joint Applications, by Region, 2021
Figure 21 : North American Market Shares of Regenerative Medicine for Bone and Joint Applications, by Technology, 2021
Figure 22 : North American Market Shares of for Regenerative Medicine for Bone and Joint Applications, by Country, 2020
Figure 23 : U.S. Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 24 : Canadian Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 25 : European Market Shares of Regenerative Medicine for Bone and Joint Applications, by Technology, 2021
Figure 26 : European Market Shares of Regenerative Medicine for Bone and Joint Applications, by Country, 2021
Figure 27 : German Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 28 : French Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 29 : U.K. Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 30 : Italian Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 31 : Spanish Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 32 : Rest of Europe Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 33 : Asia-Pacific Market Shares of Regenerative Medicine for Bone and Joint Applications, by Technology, 2021
Figure 34 : Asia-Pacific Market Shares of Regenerative Medicine for Bone and Joint Applications, by Country, 2021
Figure 35 : Chinese Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 36 : Japanese Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 37 : Australian Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 38 : Indian Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 39 : Rest of Asia-Pacific Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 40 : Rest of the World Market for Regenerative Medicine for Bone and Joint Applications, by Technology, 2021
Figure 41 : Anika Therapeutics: Net Revenue, 2017-2021
Figure 42 : Anika Therapeutics: Revenue Share, by Business Segment, 2020
Figure 43 : Anika Therapeutics: Revenue Share, by Region/Country, 2021
Figure 44 : Baxter International: Net Revenue, 2017-2021
Figure 45 : Baxter International: Revenue Share, by Business Segment, 2021
Figure 46 : Baxter International: Revenue Share, by Region/Country, 2021
Figure 47 : Bioventus: Net Revenue, 2018-2020
Figure 48 : Bioventus: Revenue Share, by Business Segment, 2020
Figure 49 : Bioventus: Revenue Share, by Region/Country, 2020
Figure 50 : Conmed Corp.: Net Revenue, 2017-2021
Figure 51 : Conmed Corp.: Revenue Share, by Business Segment, 2020
Figure 52 : Conmed Corp.: Revenue Share, by Region/Country, 2021
Figure 53 : Johnson & Johnson (DePuy Synthes Companies): Net Revenue, 2017-2021
Figure 54 : Johnson & Johnson (DePuy Synthes): Revenue Share, by Business Segment, 2021
Figure 55 : Johnson & Johnson (DePuy Synthes Companies): Revenue Share, by Region, 2021
Figure 56 : Medtronic PLC: Net Revenue, 2017-2021
Figure 57 : Medtronic PLC: Revenue Share, by Business Segment, 2021
Figure 58 : Medtronic PLC: Revenue Share, by Region, 2021
Figure 59 : Seikagaku Corp.: Net Revenue, 2016-2020
Figure 60 : Seikagaku Corp.: Revenue Share, by Business Segment, 2020
Figure 61 : Smith & Nephew: Net Revenue, 2017-2021
Figure 62 : Smith & Nephew: Revenue Share, by Business Segment, 2021
Figure 63 : Smith & Nephew: Revenue Share, by Region, 2021
Figure 64 : Stryker Corp.: Net Revenue, 2017-2021
Figure 65 : Stryker Corp.: Revenue Share, by Business Segment, 2021
Figure 66 : Stryker Corp.: Revenue Share, by Region/Country, 2021
Figure 67 : Zimmer Biomet Holdings: Net Revenue, 2016-2020
Figure 68 : Zimmer Biomet Holdings: Revenue Share, by Business Segment, 2020
Figure 69 : Zimmer Biomet Holdings: Revenue Share, by Region, 2020
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security